Skip to content

Home / News / Kindeva Appoints Brok Weichbrodt as Chief Transformation Officer to Accelerate Growth Strategy and Commercial Excellence

Kindeva Appoints Brok Weichbrodt as Chief Transformation Officer to Accelerate Growth Strategy and Commercial Excellence

July 13, 2026

Organizational

Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan.

With over 20 years of experience in the pharmaceutical and biotech sector, Brok has led large-scale transformation, built high-performing teams, and delivered complex operational programs. He previously played a key role in scaling Genezen from a start-up company into a best-in-class viral vector CDMO. Prior to Genezen, Brok led Drug Product Operations and Commercial Operations for Catalent Bloomington, successfully launching multiple commercial programs internationally. In this role, Brok will define and lead Kindeva’s transformation roadmap, aligning strategy with execution in supply chain, procurement, engineering, EHS, and ESG across all business units. He will ensure Kindeva continues to scale effectively in a highly regulated environment, while delivering consistent, high-quality outcomes for customers and patients.

“Joining Kindeva at such an exciting stage of its journey is a fantastic opportunity. I am looking forward to working with teams across the business to strengthen operational performance, accelerate strategic execution, and help position Kindeva for its next phase of sustainable growth,” commented Brok on the news.

He continued, “With experience scaling clinical and commercial organizations through significant growth, I look forward to building on our strong foundations and working with our talented teams to deliver critical products for our customers and patients.”

David Stevens, CEO at Kindeva, noted of the appointment, “Brok brings a proven track record of leading enterprise transformation and translating strategy into measurable results. His experience across operations, quality, and complex program delivery will be critical as we strengthen our global network, improve reliability, and scale the business. We are delighted to welcome him as we enter the next phase of growth.’

Find out more about Kindeva’s services here.

Share article:

Related news

Explore more of our latest news and announcements, where the demands of today meet the possibilities of tomorrow.

Kindeva Appoints Mike Cowhig as Chief Legal Officer

9TH MARCH 2026: Kindeva, a global drug delivery contract development and manufacturing organization (CDMO), has today announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization. Bringing over 25 years of experience in the life sciences industry, Mike has […]

Learn More

Kindeva Announces Leadership Transition to Drive Strategic Growth

Woodbury, Minnesota – January 15, 2026 – Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery.  Effective January 1, 2026, David Stevens, most recently […]

Learn More

Kindeva announces the appointment of David Stevens as President

Woodbury, Minnesota – 24 October 2025 – Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations. With over 20 years of experience in the […]

Learn More

Kindeva appoints Joanna Disley as VP, Brand Strategy

Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Joanna Disley as VP, Brand Strategy to drive its brand, marketing and communications strategy. In this pivotal role, Joanna will be responsible for driving Kindeva’s overall brand, marketing and communications strategy. Joanna has extensive experience in marketing and communications which includes […]

Learn More

Kindeva bolsters executive team with Chief Quality Officer appointment

ST.LOUIS, 22nd APRIL:  Kindeva, a global CDMO and drug delivery expert, has today announced the appointment of Melanie Cerullo as Chief Quality Officer to drive its quality, compliance and regulatory strategy. With a proven track record in safely delivering treatments to patients across the globe, Melanie’s appointment will bolster the organization to deliver strategic value […]

Learn More

Kindeva Appoints Daniel J. Speciale as the New Chief Financial Officer (CFO)

LOUIS, Mo. and WOODBURY, Minn., Mar. 31, 2025 – Kindeva, a global CDMO and drug delivery expert, has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the  organization. As Kindeva continues its growth trajectory, Mr. Speciale will oversee all financial  functions, ensuring strong […]

Learn More

Kindeva Drug Delivery appoints new CIO to lead digital transformation business initiatives

ST. LOUIS and WOODBURY; NOV 12 2024 –Kindeva Drug Delivery, a global CDMO and drug delivery expert, has appointed Prakash Pandian as Chief Information Officer (CIO) to bolster its executive leadership team and power technological initiatives across the organization. As Kindeva continues its digital transformation journey, Prakash will be responsible for a host of technology-enabled initiatives […]

Learn More

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, named winner of RDD Conference’s Charles G. Thiel Award

Award for Outstanding Research and Discovery in Respiratory Drug Delivery WOODBURY, Minn. and ST. LOUIS, Mo.; May 8, 2024 (Business Wire) – At the recent Respiratory Drug Delivery (RDD) Conference, John Patton, Ph.D., biotechnology scientist and entrepreneur and Head of the Scientific Advisory Board (SAB) for Kindeva Drug Delivery (KDD), a global leader in drug-device […]

Learn More

Kindeva Drug Delivery welcomes Jennifer Riter, new Vice President of Analytical Services

WOODBURY, Minn. and ST. LOUIS, Mo.; March 18, 2024 (Business Wire) – Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit. Riter comes to Kindeva from West Pharmaceutical where she spent the past […]

Learn More

Manufacturing More Tomorrows™

Partner with us and benefit from a team with technical expertise and a passion for purpose. As a true partner, strategically minded and dedicated to your lasting legacy, we provide customized solutions tailored to your precise requirements. From development to commercial manufacturing and beyond, our CDMO solutions are designed to help your product progress with purpose.